Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. Saraf A, et al. Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18. Nat Med. 2024. PMID: 38637636 Free PMC article. Clinical Trial.
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis.
Geffin R, Raheem S, Pandit LM, Hunter AS, Holliday MW Jr, Rao AV, Shah MK. Geffin R, et al. Among authors: rao av. J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231200386. doi: 10.1177/23247096231200386. J Investig Med High Impact Case Rep. 2023. PMID: 37732474 Free PMC article.
Three Cases of Bilateral, Asymptomatic Orbital Varices.
Ryu BU, Rao AV, Hasegawa N, Katz BJ, Caskey E, Seay MD, Harrie RP, Adesina OO. Ryu BU, et al. Among authors: rao av. J Neuroophthalmol. 2024 Jun 1;44(2):e265-e267. doi: 10.1097/WNO.0000000000001979. Epub 2023 Aug 15. J Neuroophthalmol. 2024. PMID: 37581928 No abstract available.
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.
Thuluva S, Paradkar V, Gunneri S, Yerroju V, Mogulla R, Suneetha PV, Turaga K, Kyasani M, Manoharan SK, Adabala S, Sri Javvadi A, Medigeshi G, Singh J, Shaman H, Binayke A, Zaheer A, Awasthi A, Singh C, Rao A V, Basu I, Kumar KAA, Pandey AK. Thuluva S, et al. Among authors: rao a v. Hum Vaccin Immunother. 2023 Dec 31;19(1):2203632. doi: 10.1080/21645515.2023.2203632. Epub 2023 Apr 27. Hum Vaccin Immunother. 2023. PMID: 37113012 Free PMC article. Clinical Trial.
375 results